immune cells

Researchers Develop New Method to Specifically Target Immune Cells that Trigger MS, Other Autoimmune Processes

Researchers atĀ Cincinnati Childrenā€™s Hospital Medical Center (CCHMC) have developed a new experimental method to specifically target unwanted activation of the immune system without the toxicity of current immunoregulatory drugs. According toĀ the study ā€œManipulating DNA damage-response signaling for the treatment of immune-mediated diseases,ā€ published in the journalĀ …

Cytomegalovirus Infection Worsens Multiple Sclerosis, Study in Mice Shows

A cytomegalovirus infection triggers an increase in inflammatory and cytotoxic immune cells in mice with multiple sclerosis (MS), which leadsĀ to enhanced inflammation and loss of nerve-protecting myelin. The study, ā€œCytomegalovirus infection exacerbates autoimmune mediated neuroinflammation,ā€ was published in the journal Scientific Reports. A cytomegalovirus (CMV) infection…

Queenā€™s University Belfast Awarded Ā£2M in Bid to Reverse Myelin Damage in MS

Researchers at Queenā€™s University BelfastĀ are studyingĀ how myelin might be repaired, in an attempt to reverse the damage caused by multiple sclerosis (MS). The more than Ā£2 million, five-year research grantĀ is jointly funded by Ā the Wellcome Trust, in its first Investigator AwardĀ forĀ Northern Ireland, and by theĀ BBSRC, the Biotechnology and Biosciences…

Biogen and AbbVie Present New Data Showing Zinbryta, an RRMS Drug Candidate, Aids Cognition Without Immune Depletion

New data presented byĀ BiogenĀ andĀ AbbVieĀ at the recent 68th annual meeting of theĀ American Academy of Neurology (AAN) showed that ZinbrytaĀ (daclizumab high-yield process) improved cognitive outcome measures in patients with relapsing forms of multiple sclerosis (RMS). Additional results ā€” from post-hoc analyses of clinicalĀ trials ā€” also offer a better…

MS Patients on Salt-heavy Diets Risk Inflammation

Findings from two studies, recently published in theĀ Journal of Clinical Investigation, indicate that high levels of salt alter the stability of the immune system and make it more susceptible to inflammation. The studies, which were led by Dr. David Hafler from Yale University and Dr. Dominik…

Could Remyelination Be Achieved in MS Using an Anti-Inflammatory Treatment?

In a recent study entitled ā€œPromotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination,ā€ researchers investigated whetherĀ sulfasalazine treatment, an anti-inflammatory and immune-modulating drug, could promote remyelination of axons in an organism model of demyelination diseases such as multiple sclerosis (MS). The study was published in the…